<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Renal & Hepatic Adjustment for Medications</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <link rel="stylesheet" href="/genralPages.css" />
  <script src="/script.js"></script>
  <script src="https://kit.fontawesome.com/834304401a.js" crossorigin="anonymous"></script>
  <style>
    body {
      font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
      font-size: 16px;
      font-weight: 500;
      line-height: 1.6;
      color: #333;
      background-image: url("/images/medications.png");
      background-size: cover;
      background-repeat: no-repeat;
      background-position: center;
    }

    main {
      max-width: 1100px;
      margin: 1.5rem auto;
      padding: 1rem;
      background-color: rgba(255, 255, 255, 0.92);
      border-radius: 8px;
    }

    h1,
    h2,
    h3 {
      color: #004a7c;
      margin-top: 0.5rem;
    }

    h1 {
      font-size: 1.6rem;
      margin-bottom: 0.5rem;
    }

    h2 {
      font-size: 1.3rem;
      margin-top: 1.5rem;
      border-bottom: 2px solid #e0e0e0;
      padding-bottom: 0.25rem;
    }

    h3 {
      font-size: 1.1rem;
      margin-top: 1rem;
    }

    p {
      margin: 0.3rem 0 0.6rem;
    }

    ul,
    ol {
      margin: 0.3rem 0 0.8rem 1.4rem;
      padding-left: 0;
    }

    li {
      margin-bottom: 0.25rem;
    }

    .highlight {
      font-weight: 700;
      color: #c0392b;
    }

    .note {
      font-size: 0.9rem;
      color: #555;
      border-left: 4px solid #f39c12;
      padding-left: 0.6rem;
      margin: 0.6rem 0;
    }

    .table-wrapper {
      width: 100%;
      overflow-x: auto;
      margin: 0.8rem 0 1.4rem;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      min-width: 600px;
      font-size: 0.9rem;
    }

    th,
    td {
      text-align: left;
      padding: 0.5rem;
      border: 1px solid #ddd;
      vertical-align: top;
    }

    th {
      background-color: #005daa;
      color: #fff;
      font-weight: 600;
    }

    tr:nth-child(even) {
      background-color: #f7f9fb;
    }

    .tag {
      display: inline-block;
      padding: 0.1rem 0.4rem;
      border-radius: 4px;
      font-size: 0.75rem;
      font-weight: 600;
      background-color: #ecf0f1;
      margin-left: 0.2rem;
    }

    .tag-renal {
      background-color: #d6eaf8;
      color: #1b4f72;
    }

    .tag-hepatic {
      background-color: #fdebd0;
      color: #7e5109;
    }

    @media (max-width: 768px) {
      main {
        margin: 0.5rem;
        padding: 0.75rem;
      }

      h1 {
        font-size: 1.3rem;
      }

      h2 {
        font-size: 1.15rem;
      }

      body {
        font-size: 15px;
        line-height: 1.5;
      }
    }
  </style>
</head>
<body>
  <header>
    <nav class="logo-container">
      <div class="logo-container">
        <h1 class="main-header">Renal &amp; Hepatic Adjustment for Medications</h1>
        <div class="navbar-icons">
          <a href="/index.html" title="Home"><i class="fa-solid fa-house" aria-hidden="true"></i></a>
        </div>
        <button class="back-button" onclick="goBack()">Back</button>
      </div>
    </nav>
  </header>

  <main>
    <section class="section">
      <h1>Medication Adjustment in Renal &amp; Hepatic Impairment</h1>
      <p>
        Many commonly used drugs in the Emergency Department are renally and/or hepatically cleared.
        In patients with kidney or liver dysfunction, doses or dosing intervals often need to be
        adjusted to avoid toxicity or under-dosing.
      </p>
      <p class="note">
        <span class="highlight">Always:</span> calculate kidney and liver function first,
        then confirm doses in an up-to-date formulary (e.g. local hospital guidelines, BNF,
        SAMF, UpToDate, Lexicomp) and discuss with a senior or pharmacist.
      </p>
    </section>

    <section class="section">
      <h2>1. Assessing Renal Function (for Dosing)</h2>
      <p>
        In adults, drug dosing is usually adjusted according to creatinine clearance (CrCl) or
        estimated GFR (eGFR).
      </p>

      <h3>Creatinine Clearance – Cockcroft–Gault (Adults)</h3>
      <p>Use actual body weight unless morbidly obese; use ideal/adjusted weight if very obese.</p>
      <ul>
        <li>
          <strong>Male:</strong><br />
          CrCl (mL/min) =
          <code>(140 − age [years]) × weight [kg] / (0.814 × serum creatinine [µmol/L])</code>
        </li>
        <li>
          <strong>Female:</strong><br />
          CrCl (mL/min) = above value × <strong>0.85</strong>
        </li>
      </ul>
      <p class="note">
        As a quick rule of thumb for dosing: dose-adjustment is usually needed when
        <strong>CrCl &lt; 60 mL/min</strong>, and becomes critical when
        <strong>CrCl &lt; 30 mL/min</strong>, but always follow the drug-specific table.
      </p>
    </section>

    <section class="section">
      <h2>2. Assessing Hepatic Function (Child–Pugh)</h2>
      <p>
        The <strong>Child–Pugh score</strong> is commonly used to stage chronic liver disease
        and guide cautious use of hepatically-metabolised drugs.
      </p>

      <h3>Child–Pugh Components</h3>
      <ul>
        <li>Bilirubin</li>
        <li>Albumin</li>
        <li>INR (or Prothrombin time)</li>
        <li>Ascites (none / mild / moderate–severe)</li>
        <li>Encephalopathy (none / grade I–II / grade III–IV)</li>
      </ul>
      <p>
        Each parameter scores 1–3 points. Total score:
        <strong>A = 5–6</strong> (mild), <strong>B = 7–9</strong> (moderate),
        <strong>C = 10–15</strong> (severe).
      </p>
      <p class="note">
        In general: avoid or greatly reduce hepatically cleared drugs in
        <strong>Child–Pugh C</strong>; use reduced doses and longer intervals in
        <strong>B</strong>; standard doses or slight reduction in <strong>A</strong>
        unless otherwise stated in guidelines.
      </p>
    </section>

    <section class="section">
      <h2>3. Examples – Common ED Medications</h2>
      <p>
        These are <strong>principles</strong> for commonly used drugs. They are not a substitute
        for a full dosing table.
      </p>

      <div class="table-wrapper">
        <table>
          <thead>
            <tr>
              <th>Medication</th>
              <th>Renal Impairment (CrCl / eGFR)</th>
              <th>Hepatic Impairment (Child–Pugh)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                Metformin
                <span class="tag tag-renal">Renal</span>
              </td>
              <td>
                • Avoid if <strong>eGFR &lt; 30 mL/min</strong>.<br />
                • Consider dose reduction and close monitoring if eGFR 30–45 mL/min.<br />
                • Monitor for lactic acidosis in any acute illness (sepsis, shock, hypoxia).
              </td>
              <td>
                • Avoid in clinically significant liver disease with hypoxia or risk of lactic acidosis.<br />
                • Use cautiously in Child–Pugh B; generally avoid in C.
              </td>
            </tr>
            <tr>
              <td>
                Warfarin
                <span class="tag tag-hepatic">Hepatic</span>
              </td>
              <td>
                • No formal dose adjustment for mild–moderate renal impairment, but bleeding risk is higher in CKD.<br />
                • Monitor INR more frequently in advanced CKD.
              </td>
              <td>
                • Metabolised in liver; effect amplified in liver failure.<br />
                • Use lower starting doses in Child–Pugh B/C with very close INR monitoring, or consider alternatives per specialist advice.
              </td>
            </tr>
            <tr>
              <td>
                Lisinopril (ACE-I)
                <span class="tag tag-renal">Renal</span>
              </td>
              <td>
                • Start with lower doses in eGFR &lt; 60 mL/min.<br />
                • Avoid dose escalation if creatinine rises &gt; 30% from baseline or K⁺ &gt; 5.5 mmol/L.<br />
                • Often avoided or used very cautiously in eGFR &lt; 30 mL/min without specialist input.
              </td>
              <td>
                • No routine adjustment in mild–moderate hepatic impairment, but start low in advanced cirrhosis due to risk of hypotension/renal hypoperfusion.
              </td>
            </tr>
            <tr>
              <td>
                Ceftriaxone
                <span class="tag tag-renal">Renal</span>
                <span class="tag tag-hepatic">Hepatic</span>
              </td>
              <td>
                • Mostly biliary excretion; standard once-daily dosing usually acceptable in mild–moderate renal impairment.<br />
                • In severe renal impairment (CrCl &lt; 10–15 mL/min), consider reducing total daily dose
                or extending interval as per local antibiotic guideline.
              </td>
              <td>
                • Use with caution in severe cholestasis/hepatic failure.<br />
                • Avoid very high doses in combined severe renal + hepatic impairment; follow local guidelines.
              </td>
            </tr>
            <tr>
              <td>
                Vancomycin (IV)
                <span class="tag tag-renal">Renal – major</span>
              </td>
              <td>
                • <strong>Renally cleared.</strong> Dose entirely based on CrCl/eGFR and
                measured levels (trough or AUC depending on local protocol).<br />
                • In ED: give loading dose if severe sepsis, then follow hospital vancomycin
                nomogram.
              </td>
              <td>
                • No standard dose change in isolated hepatic impairment, but monitor closely in multi-organ failure.
              </td>
            </tr>
            <tr>
              <td>
                Azithromycin
                <span class="tag tag-hepatic">Hepatic</span>
              </td>
              <td>
                • No adjustment for mild–moderate renal impairment; use caution in CrCl &lt; 10 mL/min.
              </td>
              <td>
                • Mainly hepatically cleared.<br />
                • Avoid or use with great caution in clinically significant hepatic impairment or
                  active cholestatic hepatitis; consider alternative antibiotic.
              </td>
            </tr>
          </tbody>
        </table>
      </div>

      <p class="note">
        Values and thresholds above are deliberately conservative for teaching. Always check your
        local renal-dosing guideline and antibiogram (e.g. “Renal Drug Handbook”, local antibiotic
        book, BNF, SAMF).
      </p>
    </section>

    <section class="section">
      <h2>4. Practical Step-by-Step Approach in the ED</h2>
      <ol>
        <li>
          <strong>Check labs:</strong> urea, creatinine, eGFR, LFTs (ALT/AST, ALP, GGT, bilirubin),
          albumin, INR.
        </li>
        <li>
          <strong>Estimate function:</strong> calculate CrCl (Cockcroft–Gault) and estimate Child–Pugh
          class if cirrhosis is suspected/known.
        </li>
        <li>
          <strong>Identify high-risk drugs:</strong> renally cleared antibiotics (e.g. gentamicin,
          vancomycin), metformin, DOACs, opioids, sedatives, ACE-Is/ARBs, LMWH, etc.
        </li>
        <li>
          <strong>Check a trusted dosing reference:</strong> local guideline, BNF/SAMF, or electronic
          prescribing system, and adjust dose/interval accordingly.
        </li>
        <li>
          <strong>Document clearly:</strong> “Dose adjusted for renal/hepatic impairment – CrCl XX mL/min,
          Child–Pugh B”, and review once labs or clinical state change.
        </li>
      </ol>
      <p class="note">
        When unsure, it is safer to give a <strong>reduced dose with planned review</strong> than a full
        dose that may cause toxicity – but in life-threatening sepsis, loading doses should not be
        omitted. Discuss with ICU/senior/clinical pharmacist where available.
      </p>
    </section>
  </main>
</body>
</html>
